Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 21st:
Annovis Bio, Inc. (ANVS - Free Report) : This clinical-stage drug platform company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.
Annovis’ shares gained 14.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of A.
Arcellx, Inc. (ACLX - Free Report) : This immunotherapy-focused clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 173.5% over the last 60 days.
Arcellx’s shares gained 10.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.
Worthington Industries, Inc. (WOR - Free Report) : This industrial manufacturing company focused on value-added steel processing has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.
Worthington’s shares gained 16.8% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Reveals ChatGPT "Sleeper" Stock
One little-known company is at the heart of an especially brilliant Artificial Intelligence sector. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.
As a service to readers, Zacks is providing a bonus report that names and explains this explosive growth stock and 4 other "must buys." Plus more.
Download Free ChatGPT Stock Report Right Now >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 21st:
Annovis Bio, Inc. (ANVS - Free Report) : This clinical-stage drug platform company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.
Annovis’ shares gained 14.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of A.
Arcellx, Inc. (ACLX - Free Report) : This immunotherapy-focused clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 173.5% over the last 60 days.
Arcellx’s shares gained 10.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.
Worthington Industries, Inc. (WOR - Free Report) : This industrial manufacturing company focused on value-added steel processing has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.
Worthington’s shares gained 16.8% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Reveals ChatGPT "Sleeper" Stock
One little-known company is at the heart of an especially brilliant Artificial Intelligence sector. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.
As a service to readers, Zacks is providing a bonus report that names and explains this explosive growth stock and 4 other "must buys." Plus more.
Download Free ChatGPT Stock Report Right Now >>
Get the latest research report on WOR - FREE
Get the latest research report on ANVS - FREE
Get the latest research report on ACLX - FREE